$EVMN

$8.77▲ -8.6% YTD

5 SEC 13D/G filings tracked · Last updated Sep 23, 2026

Filing History

CP $8.77▲ -8.6%Sep 23, 2026 · ThinkSabio Blog

$EVMN - Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology…

News

EVMN ▼ -8.6% - Evommune, Inc.

CP $8.77▲ -8.6%Sep 23, 2026 · ThinkSabio Blog

$EVMN Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2…

News

EVMN ▼ -13.6% - Evommune, Inc.

CP $10.61▲ -13.6%Sep 8, 2026 · ThinkSabio Blog

$EVMN down ah…

News

EVMN ▼ -25.2% - Evommune, Inc.

CP $9.19▲ -25.2%Sep 8, 2026 · ThinkSabio Blog

$EVMN - Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Atopic Dermatitis…

SEC 13D/G

$EVMN SEC Filing Update (16-JUL-2026) | ThinkSabio - Stocks Simplified

$12.13▼ -29.92%Jul 16, 2026 · ThinkSabio Blog

$EVMN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #EVMN : $12.13 Sector: Healthcare | YTD: 🔽 -29.92% The SEC discl…